Title : HP1γ Sensitizes Cervical Cancer Cells to Cisplatin through the Suppression of UBE2L3.

Pub. Date : 2020 Aug 19

PMID : 32825184






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As a follow-up study of our previous findings, here we have identified that the pharmacological substances, leptomycin B and doxorubicin, can improve the sensitivity of cervical cancer cells to cisplatin inducing HP1gamma-mediated elevation of p53. Cisplatin tumor protein p53 Homo sapiens
2 Leptomycin B, which inhibits the nuclear export of HP1gamma, increased cisplatin-dependent apoptosis induction by promoting the activation of p53 signaling. Cisplatin tumor protein p53 Homo sapiens
3 Doxorubicin sensitized the cisplatin-resistant cervical cancer cells, enhancing their p53 levels and rate of apoptosis when administered together with cisplatin. Cisplatin tumor protein p53 Homo sapiens
4 Our findings reveal a therapeutic strategy to target a specific molecular pathway that contributes to p53 degradation for the treatment of patients with cervical cancer, particularly with cisplatin resistance. Cisplatin tumor protein p53 Homo sapiens